EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of spleen volume and volume change in non-Hodgkin lymphoma treated with chimeric antigen receptor t-cell therapy

Christina Quell, Wolfgang G Kunz, Viktoria Blumenberg, Kai Rejeski, Veit L Bücklein, Maria Ingenerf, Christian Schmidt, Gabriel T Sheikh, Matthias Brendel, Jens Ricke, Michael von Bergwelt-Baildon, Marion Subklewe und 1 weitere

Cancer Treatment and Research Communications · 2026 · 46 · 101080

DOI: 10.1016/j.ctarc.2025.101080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Christina Quell und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Spleen, Lymphoma, Non-Hodgkin, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Cancer Consortium, Ludwig-Maximilians-Universität München, Else Kroner-Fresenius Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpleenLymphoma, Non-HodgkinImmunotherapy, AdoptiveReceptors, Chimeric AntigenHumansFemaleMaleMiddle AgedAgedAdultPositron Emission Tomography Computed TomographyRetrospective Studies

Stichwörter der Autor:innen

CAR T-cell therapyImmunotherapyNon-Hodgkin-LymphomaSpleen

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Department of Radiology, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany; Comprehensive Cancer Cente…
  • Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany; Depar…
  • German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; Adult Bone Marrow Trans…
  • Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Förderung

  • German Cancer Consortium
  • Ludwig-Maximilians-Universität München
  • Else Kroner-Fresenius Foundation

Zitieren

APA

Quell, C., Kunz, W. G., Blumenberg, V., Rejeski, K., Bücklein, V. L., Ingenerf, M., Schmidt, C., Sheikh, G. T., Brendel, M., Ricke, J., von Bergwelt-Baildon, M., Subklewe, M., & Winkelmann, M. (2026). Impact of spleen volume and volume change in non-Hodgkin lymphoma treated with chimeric antigen receptor t-cell therapy. Cancer Treatment and Research Communications, 46, 101080. https://doi.org/10.1016/j.ctarc.2025.101080

Vancouver

Quell C, Kunz WG, Blumenberg V, Rejeski K, Bücklein VL, Ingenerf M, et al. Impact of spleen volume and volume change in non-Hodgkin lymphoma treated with chimeric antigen receptor t-cell therapy. Cancer Treatment and Research Communications. 2026;46:101080. doi:10.1016/j.ctarc.2025.101080

BibTeX
@article{Quell2026,
  author = {Quell, Christina and Kunz, Wolfgang G and Blumenberg, Viktoria and Rejeski, Kai and Bücklein, Veit L and Ingenerf, Maria and Schmidt, Christian and Sheikh, Gabriel T and Brendel, Matthias and Ricke, Jens and von Bergwelt-Baildon, Michael and Subklewe, Marion and Winkelmann, Michael},
  title = {Impact of spleen volume and volume change in non-Hodgkin lymphoma treated with chimeric antigen receptor t-cell therapy},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {46},
  pages = {101080},
  doi = {10.1016/j.ctarc.2025.101080}
}
Kostenlos starten →